1.Cassini, A et al. (2018) Impact of infectious diseases on population health using incidence based disability-adjusted life years (DALYs): results from the burden of communicable diseases in Europe study, European Union and European Economic countries, 2009 to 2013. Eurosurveillance 23, pii = 17-00454.
3.Rota, PA et al. (1990) Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983. Virology 175, 59–68.
4.Kuo, SM et al. (2016) Circulating pattern and genomic characteristics of influenza B viruses in Taiwan from 2003 to 2014. Journal of the Formosan Medical Association 115, 510–522.
5.Sharabi, S et al. (2016) Epidemiological and virological characterization of influenza B virus infections. PLoS ONE 11, e0161195.
6.Caini, S et al. (2015) Epidemiological and virological characteristics of influenza B: results of the Global influenza B study. Influenza and Other Respiratory Viruses suppl. 1, 3–12.
7.Gutierrez-Pizarraya, A et al. (2012) Unexpected severity of cases of influenza B infection in patients that required hospitalization during the first postpandemic wave. Journal of Infection 65, 423–430.
8.Glezen, PW et al. (2013) The burden of influenza B: a structured literature review. American Journal of Public Health 103, e43–e51.
9.Caton, AJ et al. (1982) The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 31, 417–427.
10.Wiley, DC, Wilson, IA and Skehel, JJ (1981) Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289, 373–378.
11.Wang, Q et al. (2008) Crystal structure of unliganded influenza B virus hemagglutinin. Journal of Virology 82, 3011–3020.
12.Koel, BF et al. (2013) Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution. Science 342, 976–979.
13.Skehel, JJ et al. (1984) A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody. Proceedings of the National Academy of Sciences of the USA 81, 1779–1783.
16.Shu, B et al. (2011) Design and performance of the CDC real-time reverse transcriptase PCR swine flu panel for detection of 2009 A(H1N1) pandemic influenza virus. Journal of Clinical Microbiology 49, 2614–2619.
17.Matrosovich, M et al. (2003) Over expression of the a-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors. Journal of Virology 77, 8418–8425.
18.Shu, Y and McCauley, J (2017) GISAID: Global initiative on sharing all influenza data – from vision to reality. Eurosurveillance 22, pii: 30494.
19.Tamura, K et al. (2013) MEGA6: molecular evolutionary genetics analysis version 6.0. Molecular Biology and Evolution 30, 2725–2729.
20.CDC (2017) Update: influenza activity in the United States during the 2016–17 season and composition of the 2017–18 influenza vaccine. Morbidity and Mortality Weekly Report 66, 668–676.
22.Tewawong, N et al. (2015) Molecular epidemiology and phylogenetic analyses of influenza B virus in Thailand during 2010 to 2014. PLoS ONE 10, e0116302.
23.de la Rosa-Zamboni, D et al. (2012) Molecular characterization of the predominant influenza A(H1N1)pdm09 virus in Mexico, December 2011 – February 2012. PLoS ONE 7, e50116.
24.Fang, Q et al. (2014) Molecular epidemiology and evolution of A(H1N1)pdm09 and H3N2 virus during winter 2012–2013 in Beijing, China. Infection, Genetics and Evolution 26, 228–240.
26.Adlhoch, C et al. (2018) Dominant influenza A(H3N2) and B/Yamagata virus circulation in EU/EEA, 2016/17 and 2017/18 seasons, respectively. Eurosurveillance 23, pii = 18-00146.
27.Korsun, N, Angelova, S and Teodosieva, A (2016) Virological surveillance of influenza in four recent post-pandemic seasons (2010/11 to 2013/14) in Bulgaria. Central European Journal of Public Health 24, 180–187.
28.Horthongkham, N et al. (2016) Epidemiological, clinical and virological characteristics of influenza B virus from patients at the hospital tertiary care units in Bangkok during 2011–2014. PLoS ONE 1, e0158244.
29.Yang, J et al. (2018) Variation in influenza B virus epidemiology by lineage, China. Emerging Infectious Diseases Journal 24, 1536–1540.
30.Chen, R and Holmes, EC (2008) The evolutionary dynamics of human influenza B virus. Journal of Molecular Evolution 66, 655–663.
31.Nobusawa, E and Sato, K (2006) Comparison of the mutation rates of human influenza A and B viruses. Journal of Virology 80, 3675–3678.
32.Tewawong, N et al. (2017) Evidence for influenza B virus lineage shifts and reassortants circulating in Thailand in 2014–2016. Infection Genetics and Evolution 47, 35–40.
33.Oong, XY et al. (2017) Whole-genome phylogenetic analysis of influenza B/Phuket/3073/2013-like viruses and unique reassortants detected in Malaysia between 2012 and 2014. PLoS ONE 12, e0170610.
34.Monamele, CG et al. (2018) Genetic characterization of influenza B virus in Cameroon and high frequency of reassortant strains. Journal of Medical Virology 90, 1848–1855.
35.Yang, LR et al. (2012) Phylogenetic and evolutionary history of influenza B viruses, which caused a large epidemic in 2011–2012, Taiwan. PLoS ONE 7, e47179.
36.Tramuto, F et al. (2016) The molecular epidemiology and evolutionary dynamics of influenza B virus in two Italian regions during 2010–2015: the experience of Sicily and Liguria. International Journal of Molecular Sciences 17, 1–15.
37.Allen, JD and Ross, TM (2018) H3N2 influenza viruses in humans: vira mechanisms, evolution, and evaluation. Human Vaccines & Immunotherapeutics 14, 1840–1847.
38.Bedford, T et al. (2014) Integrating influenza antigenic dynamics with molecular evolution. Elife 3, e01914.
39.Pariani, E et al. (2015) Ten years (2004–2014) of influenza surveillance in Northern Italy. Human Vaccines & Immunotherapeutics 11, 198–205.
40.Seleka, M et al. (2017) Epidemiology of influenza B/Yamagata and B/Victoria lineages in South Africa, 2005–2014. PLoS ONE 12, e0177655.